Market by Product, Technology, Application, Industry Vertical, and Country Outlook | Forecast 2021-2028
According
to Triton Market Research, the Latin America DNA sequencing market is poised to
expand with a CAGR of 16.14% over the forecasting years 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries considered in this market include:
• Brazil
• Mexico
• Rest of Latin America countries
Mexico
is an upper-middle-income country in Latin America. Influenced by medical and
technological advancements, the nation is going through an epidemiologic
transition. The market here is driven by the rising adoption of personalized
medicine as well as the enhanced applications of DNA sequencing. In fact, Mexico
was one of the first few nations to adopt genomics research in the Americas.
This can be attributed to next-generation DNA sequencing, as the NGS testing
capabilities have immensely helped solve persisting challenges such as complex
data analysis. Moreover, several major players in the market are focusing on developing
new technologies and R&D activities in Mexico, which is expected to drive
the growth of its DNA sequencing market.
Meanwhile,
the economic development in Brazil has resulted in increased investments in the
country’s healthcare system. This has led to a rise in the spending on high-end
biotechnology instruments for clinical research and diagnostics, along with the
data analysis associated with it. The rise in R&D activities for genome
sequencing is expected to positively influence the growth of the market
studied. Companies are also making efforts to grow their presence in the
country, which is expected to further augment the market growth. For instance,
in February 2020, MGI Tech signed a contract with Brazil’s Datamed to increase
the adoption of DNA sequencing and products for laboratory automation in
Brazil. The aforementioned factors are expected to foster the growth of the
Brazilian DNA sequencing market over the coming years.
Bio-Rad
Laboratories Inc (Bio-Rad) is a company operating in the field of life sciences
research. It also manufactures medical devices. The company’s major life
sciences products include consumables, medical instruments, reagents, and
software, focused in the fields of gene expression, cell biology, protein
quantification, protein purification, and drug discovery & manufacturing. Founded
in 1952, Bio-Rad operates in Latin America, Europe, among other regions.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA DNA SEQUENCING MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE DNA SEQUENCING MARKET
2.2. KEY
INSIGHTS
2.2.1. APPLICATIONS
OF LIQUID BIOPSY
2.2.2. EMERGING
DEVELOPING ECONOMIES
2.2.3. DEVELOPMENT
IN PERSONALIZED MEDICINE AND BIOMARKER DISCOVERY
2.2.4. NEXT
GENERATION SEQUENCING
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. INDUSTRY
COMPONENTS
2.5. KEY
IMPACT ANALYSIS
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. VENDOR
SCORECARD
2.8. KEY
MARKET STRATEGIES
2.8.1. CONTRACTS
AND PARTNERSHIPS
2.8.2. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
2.8.3. ACQUISITIONS
& MERGERS
2.8.4. NEW
PRODUCT LAUNCHES
2.9. MARKET
DRIVERS
2.9.1. PREVALENCE
OF CANCER CASES
2.9.2. ADVANCEMENTS
IN TECHNOLOGY
2.9.3. APPLICATIONS
OF DNA SEQUENCING FOR ANIMALS & PLANTS REPRODUCTION
2.10. MARKET
RESTRAINTS
2.10.1. CHALLENGES
ASSOCIATED WITH DNA SEQUENCING TECHNOLOGIES IN BIOINFORMATICS
2.10.2. LACK
OF SKILLED PROFESSIONALS IN EMERGING ECONOMIES
2.10.3. LIMITATIONS
OF DNA SEQUENCING TECHNOLOGY IN DIAGNOSTIC TESTING
2.11. MARKET
OPPORTUNITIES
2.11.1. EXTENSIVE
RESEARCH AND DEVELOPMENT IN DNA SEQUENCING
2.11.2. GROWTH
IN GENOME MAPPING PROGRAMS
3. LATIN
AMERICA DNA SEQUENCING MARKET – BY PRODUCT
3.1. INSTRUMENTS
& CONSUMABLES
3.1.1. INSTRUMENTS
& CONSUMABLES TYPE
3.1.1.1. CONSUMABLES
3.1.1.2. INSTRUMENTS
3.1.2. INSTRUMENTS
& CONSUMABLES PLATFORM
3.1.2.1. NGS
(NEXT GENERATION SEQUENCING)
3.1.2.1.1. RNA
SEQUENCING
3.1.2.1.2. TARGETED
RESEQUENCING
3.1.2.1.3. WHOLE-EXOME
SEQUENCING
3.1.2.1.4. WHOLE-GENOME
SEQUENCING
3.1.2.1.5. CHIP
SEQUENCING
3.1.2.1.6. DE
NOVO SEQUENCING
3.1.2.1.7. METHYL
SEQUENCING
3.1.2.2. SANGER
3.2. SEQUENCING
SERVICES
3.3. BIOINFORMATICS
4. LATIN
AMERICA DNA SEQUENCING MARKET – BY TECHNOLOGY
4.1. SEQUENCING
BY SYNTHESIS
4.2. ION
SEMICONDUCTOR SEQUENCING
4.3. CHAIN
TERMINATION SEQUENCING
4.4. PYROSEQUENCING
4.5. SEQUENCING
BY LIGATION (SBL)
4.6. SINGLE-MOLECULE
REAL-TIME SEQUENCING (SMRT)
4.7. NANOPORE
SEQUENCING
4.8. OTHER
TECHNOLOGIES
5. LATIN
AMERICA DNA SEQUENCING MARKET – BY APPLICATION
5.1. BIOMARKER
DISCOVERY
5.2. DIAGNOSTICS
5.3. REPRODUCTIVE
HEALTH
5.4. PERSONALIZED
MEDICINE
5.5. DRUG
DISCOVERY
5.6. AGRICULTURE
& ANIMAL RESEARCH
5.7. FORENSICS
5.8. OTHER
APPLICATIONS
6. LATIN
AMERICA DNA SEQUENCING MARKET – BY INDUSTRY VERTICALS
6.1. RESEARCH
CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
6.2. PHARMACEUTICAL
6.3. BIOTECHNOLOGY
COMPANIES
6.4. HOSPITALS
& CLINICS
6.5. OTHER
INDUSTRY VERTICALS
7. LATIN
AMERICA DNA SEQUENCING MARKET – COUNTRY OUTLOOK
7.1. MEXICO
7.2. BRAZIL
7.3. REST
OF LATIN AMERICA
8. COMPETITIVE
LANDSCAPE
8.1. ADAPTIVE
BIOTECHNOLOGIES INC
8.2. AGILENT
TECHNOLOGIES INC
8.3. ASURAGEN
INC
8.4. BGI
GENOMICS
8.5. BIO-RAD
LABORATORIES INC
8.6. DANAHER
CORPORATION (INTEGRATED DNA TECHNOLOGIES INC)
8.7. EUROFINS
SCIENTIFIC
8.8. F
HOFFMANN-LA ROCHE
8.9. ILLUMINA
INC
8.10. MERCK
KGAA
8.11. PACIFIC
BIOSCIENCES OF CALIFORNIA INC
8.12. PERKINELMER
INC
8.13. SIEMENS
HEALTHINEERS AG
8.14. SPIRAL
GENETICS INC
8.15. THERMO
FISHER SCIENTIFIC INC
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: LATIN AMERICA DNA SEQUENCING MARKET,
COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: CONTRACTS AND PARTNERSHIPS
TABLE 4: BUSINESS EXPANSIONS, ANNOUNCEMENTS &
DIVESTITURES
TABLE 5: ACQUISITIONS & MERGERS
TABLE 6: NEW PRODUCT LAUNCHES
TABLE 7: LATIN AMERICA DNA SEQUENCING MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 8: LATIN AMERICA INSTRUMENTS &
CONSUMABLES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: LATIN AMERICA INSTRUMENTS &
CONSUMABLES MARKET, BY PLATFORM, 2021-2028 (IN $ MILLION)
TABLE 10: LATIN AMERICA NGS MARKET, BY TYPE,
2021-2028 (IN $ MILLION)
TABLE 11: LATIN AMERICA DNA SEQUENCING MARKET, BY
TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 12: LATIN AMERICA DNA SEQUENCING MARKET, BY
APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 13: LATIN AMERICA DNA SEQUENCING MARKET, BY
INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 14: LATIN AMERICA DNA SEQUENCING MARKET,
COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: LATIN AMERICA DNA
SEQUENCING MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: LIMITATIONS OF DNA
SEQUENCING IN DIAGNOSTIC TESTING
FIGURE 3: LATIN AMERICA DNA
SEQUENCING MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 4: LATIN AMERICA DNA
SEQUENCING MARKET, BY INSTRUMENTS & CONSUMABLES, 2021-2028 (IN $ MILLION)
FIGURE 5: LATIN AMERICA
INSTRUMENTS & CONSUMABLES MARKET, BY CONSUMABLES, 2021-2028 (IN $ MILLION)
FIGURE 6: LATIN AMERICA
INSTRUMENTS & CONSUMABLES MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 7: LATIN AMERICA
INSTRUMENTS & CONSUMABLES MARKET, BY NGS, 2021-2028 (IN $ MILLION)
FIGURE 8: LATIN AMERICA NGS
MARKET, BY RNA SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 9: LATIN AMERICA NGS
MARKET, BY TARGETED RESEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 10: LATIN AMERICA NGS
MARKET, BY WHOLE-EXOME SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 11: LATIN AMERICA NGS
MARKET, BY WHOLE-GENOME SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 12: LATIN AMERICA NGS MARKET,
BY CHIP SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 13: LATIN AMERICA NGS
MARKET, BY DE NOVO SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 14: LATIN AMERICA NGS
MARKET, BY METHYL SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 15: LATIN AMERICA
INSTRUMENTS & CONSUMABLES MARKET, BY SANGER, 2021-2028 (IN $ MILLION)
FIGURE 16: LATIN AMERICA DNA
SEQUENCING MARKET, BY SEQUENCING SERVICES, 2021-2028 (IN $ MILLION)
FIGURE 17: LATIN AMERICA DNA
SEQUENCING MARKET, BY BIOINFORMATICS, 2021-2028 (IN $ MILLION)
FIGURE 18: LATIN AMERICA DNA
SEQUENCING MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 19: LATIN AMERICA DNA
SEQUENCING MARKET, BY SEQUENCING BY SYNTHESIS, 2021-2028 (IN $ MILLION)
FIGURE 20: LATIN AMERICA DNA
SEQUENCING MARKET, BY ION SEMICONDUCTOR SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 21: LATIN AMERICA DNA
SEQUENCING MARKET, BY CHAIN TERMINATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 22: LATIN AMERICA DNA
SEQUENCING MARKET, BY PYROSEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 23: LATIN AMERICA DNA SEQUENCING
MARKET, BY SEQUENCING BY LIGATION (SBL), 2021-2028 (IN $ MILLION)
FIGURE 24: LATIN AMERICA DNA
SEQUENCING MARKET, BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT), 2021-2028
(IN $ MILLION)
FIGURE 25: LATIN AMERICA DNA
SEQUENCING MARKET, BY NANOPORE SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 26: LATIN AMERICA DNA
SEQUENCING MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 27: LATIN AMERICA DNA
SEQUENCING MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 28: LATIN AMERICA DNA
SEQUENCING MARKET, BY BIOMARKER DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 29: LATIN AMERICA DNA
SEQUENCING MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 30: LATIN AMERICA DNA
SEQUENCING MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 31: LATIN AMERICA DNA
SEQUENCING MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)
FIGURE 32: LATIN AMERICA DNA
SEQUENCING MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 33: LATIN AMERICA DNA
SEQUENCING MARKET, BY AGRICULTURE & ANIMAL RESEARCH, 2021-2028 (IN $
MILLION)
FIGURE 34: LATIN AMERICA DNA
SEQUENCING MARKET, BY FORENSICS, 2021-2028 (IN $ MILLION)
FIGURE 35: LATIN AMERICA DNA
SEQUENCING MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 36: LATIN AMERICA DNA
SEQUENCING MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 37: LATIN AMERICA DNA
SEQUENCING MARKET, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT
INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 38: LATIN AMERICA DNA
SEQUENCING MARKET, BY PHARMACEUTICAL, 2021-2028 (IN $ MILLION)
FIGURE 39: LATIN AMERICA DNA
SEQUENCING MARKET, BY BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 40: LATIN AMERICA DNA
SEQUENCING MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 41: LATIN AMERICA DNA
SEQUENCING MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 42: MEXICO DNA SEQUENCING
MARKET 2021-2028 ($ MILLION)
FIGURE 43: BRAZIL DNA SEQUENCING
MARKET 2021-2028 ($ MILLION)
FIGURE 44: REST OF LATIN AMERICA
DNA SEQUENCING MARKET 2021-2028 ($ MILLION)